Tedder Richard S, Ijaz Samreen, Kitchen Alan, Ushiro-Lumb Ines, Tettmar Kate I, Hewitt Patricia, Andrews Nick
Virus Reference Department, National Infection Service, Public Health England, London, UK.
NHS Blood and Transplant, London, UK.
Transfusion. 2017 Feb;57(2):267-272. doi: 10.1111/trf.13976.
Infection with hepatitis E virus (HEV) Genotype 3 is recognized as a food-borne zoonosis in developed countries where it usually causes a mild self-limited acute hepatitis. It may cause a persistent infection in the immunosuppressed human that can progress to cirrhosis. To protect the patient from transfusion-acquired HEV infection, steps have been taken in the United Kingdom to provide for at-risk patients only components from donors screened for HEV viremia. This strategy does not protect from dietary exposure and calls into question estimation of relative risk between blood transfusion and diet.
Using data on HEV viremia, component exposure, residual plasma volume, and resulting transmission, the dose of virus administered and subsequent transmission rates were determined and used to populate a model that can infer the relationship between blood and dietary exposure.
The annual attack rate of a population, defined as seroconversion, provides an estimate of the risk of receiving a component containing HEV from a viremic donor. The lowest viral dose that resulted in infection was 2 × 10 IUs and 55% of components containing this dose transmitted infection. The transfusion risk of infection only exceeds the annual dietary risk when more than 13 individual donor components are transfused.
For many solid organ transplant patients dietary exposure far exceeds the risk of transfusion from unscreened donors. It is only in the immunosuppressed patient requiring extensive blood component support that transfusion risk dominates. This understanding should inform policy decisions on HEV RNA screening of blood donations.
在发达国家,戊型肝炎病毒(HEV)3型感染被认为是一种食源性人畜共患病,通常会引发轻度自限性急性肝炎。它可能会在免疫抑制人群中引发持续感染,并可能发展为肝硬化。为保护患者免受输血获得性戊型肝炎感染,英国已采取措施,只为有风险的患者提供来自经戊型肝炎病毒血症筛查的献血者的成分血。这一策略无法预防饮食接触感染,也引发了对输血与饮食相对风险评估的质疑。
利用关于戊型肝炎病毒血症、成分血接触、残余血浆量及由此导致的传播的数据,确定所输入的病毒剂量及后续传播率,并用于构建一个模型,该模型可推断血液接触与饮食接触之间的关系。
以血清学转换定义的人群年发病率可估算从病毒血症献血者处接受含戊型肝炎病毒成分血的风险。导致感染的最低病毒剂量为2×10国际单位,含此剂量的成分血有55%传播了感染。仅当输入超过13个个体献血者的成分血时,输血感染风险才会超过年饮食感染风险。
对于许多实体器官移植患者而言,饮食接触感染的风险远远超过未筛查献血者输血感染的风险。只有在需要大量血液成分支持的免疫抑制患者中,输血感染风险才占主导。这一认识应为关于献血者戊型肝炎病毒RNA筛查的政策决策提供参考。